DekaBank Deutsche Girozentrale raised its position in shares of CME Group Inc. (NASDAQ:CME) by 0.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 253,076 shares of the financial services provider’s stock after purchasing an additional 1,084 shares during the quarter. DekaBank Deutsche Girozentrale owned 0.07% of CME Group worth $32,111,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of CME. Fiduciary Trust Co. purchased a new position in CME Group during the second quarter valued at approximately $105,000. Quadrant Capital Group LLC lifted its holdings in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares in the last quarter. San Francisco Sentry Investment Group CA purchased a new position in shares of CME Group in the second quarter worth $129,000. Whittier Trust Co. lifted its holdings in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares in the last quarter. Finally, People s United Financial Inc. lifted its holdings in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares in the last quarter. 82.63% of the stock is currently owned by institutional investors and hedge funds.
In other CME Group news, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $126.65, for a total transaction of $107,652.50. Following the transaction, the director now owns 13,799 shares in the company, valued at $1,747,643.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $136.83, for a total transaction of $342,075.00. The disclosure for this sale can be found here. Insiders sold 11,339 shares of company stock worth $1,548,086 in the last 90 days. 0.57% of the stock is currently owned by company insiders.
Several equities analysts have recently commented on the stock. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Citigroup Inc. boosted their target price on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Royal Bank Of Canada boosted their target price on shares of CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a report on Monday, October 16th. Barclays PLC boosted their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Finally, Wells Fargo & Company boosted their target price on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a report on Wednesday, October 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company’s stock. CME Group has an average rating of “Buy” and an average target price of $138.89.
Shares of CME Group Inc. (CME) traded up $0.66 on Tuesday, reaching $140.81. 387,367 shares of the company traded hands, compared to its average volume of 1,364,276. CME Group Inc. has a 12 month low of $111.19 and a 12 month high of $141.07. The company has a market capitalization of $47,450.00, a PE ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.71. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter in the previous year, the business posted $1.05 earnings per share. CME Group’s quarterly revenue was up 5.8% on a year-over-year basis. analysts anticipate that CME Group Inc. will post 4.8 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.87%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio is presently 59.86%.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.